NeoStrata Teams with Avon on Anew Clinical Pro Line Eraser

September 17, 2012

In collaboration with NeoStrata Company, Avon has expanded its Anew line with products featuring A-F33, a newly discovered anti-aging molecule. In Anew Clinical Pro Line Eraser, A-F33 (Aminofill-33) is said to deactivate critical collagen blocking in skin cells to encourage formation of collagen. A-F33 is formulated to help stimulate skin cells to produce skin matrix components. According to Avon, Anew Clinical Pro Line Eraser helps begin to reduce the look of deep and fine wrinkles in seven days. In studies reported by the company, all subjects had reduction in fine lines, and researchers identified up to a 50 percent improvement in overall fine lines and deep wrinkles at 11 weeks. The product, available for $54, debuts this month.

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free